ng-nitroarginine methyl ester has been researched along with Critical Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debaveye, Y; Ellger, B; Giulietti, A; Herijgers, P; Langouche, L; Mathieu, C; Van den Berghe, G; Van Etten, E; Vanhorebeek, I | 1 |
| Hwang, TL; Lau, YT; Yang, JT | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Critical Illness
| Article | Year |
|---|---|
Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.
Topics: Acetylcholine; Amino Acids; Animals; Aorta; Blood Glucose; Burns; Critical Illness; Glucose; In Vitro Techniques; Insulin; Models, Animal; NG-Nitroarginine Methyl Ester; Norepinephrine; Rabbits; Reference Values; Survival; Vasoconstriction | 2006 |
Arginine-nitric oxide pathway in plasma membrane of rat hepatocytes during early and late sepsis.
Topics: Animals; Arginine; Bacteremia; Biological Transport; Cell Membrane; Critical Illness; Disease Progression; Enzyme Inhibitors; Guanidines; Liver; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prospective Studies; Rats; Rats, Sprague-Dawley | 1999 |